| Page | Page | |||
|---|---|---|---|---|
| Report ofthe Trustees | I | to | 3 | |
| Independent Examiner's |
Report | |||
| Statement ofFinancial | Activities | |||
| Balance Sheet | ||||
| Cash Flow Statement | ||||
| Notes to the Cash Flow | Statement | |||
| Notes to the Financial Statements | 9 | to | 19 | |
| Detailed Statement of Financial Activities | 20 |
| 2021 | 2020 | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| fund | funds | funds | funds | |||
| Notes | ||||||
| INCOME AND ENDOWMENTS FROM Donations and legaoies |
2 | 298,731 | 77,745 | 376,476 | 1,244,695 | |
| Other trading activities Investment income |
3 4 |
126&194 128 |
3,807 | 130,001 128 |
245,651 239 |
|
| Total | 425&053 | 81,552 | 506,605 | 1,490,585 | ||
| EXPENDITURE ON Raising funds |
5 | 56&768 | 56&768 | 187,304 | ||
| Charitable activities |
||||||
| Medical equipment costs Other donations |
190 371&128 |
3,700 240,939 |
3&890 612,067 |
1,368,226 | ||
| Other | 1,200 | 1&200 | 2,400 | |||
| Total | 429,286 | 244,639 | 673,925 | 1,557,930 | ||
| NET INCOME/(EXPENDITURE&) | (4&233) | (163,087) | (167,320) | (67,345) | ||
| Transfers between funds |
15 | (72,298) | 72&298 | |||
| Net movement in funds |
(76,531) | (90,789) | (167420) | (67,345) | ||
| RECONCILIATION | OF I&UNDS | |||||
| Total funds brought | fomvard | 76,531 | 90,789 | 167&320 | 234„665 | |
| TOTAL FUNDS CARRIED FORWARD | 167,320 |
| 2021 | 2020 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| fund | funds | funds | firnds | ||
| Notes | f. | ||||
| CURRENT ASSETS Debtors Cash at bank |
13 | 54,246 5,455 |
54,246 5,455 |
23,409 98J,541 |
|
| 59,701 | 59,701 | L 006,950 | |||
| CREDITORS | |||||
| Amounts falling due within one year |
14 | (59,701) | (59,701) | (839,630) | |
| NET CURRENT ASSETS | 167,320 | ||||
| TOTAL ASSETSLESS CURRENT LIABILITIES |
167,320 | ||||
| NET ASSETS | 167,320 | ||||
| FUNDS Unrestricted funds Restricted funds |
15 | 76,531 90,789 |
|||
| 167,320 |
| 2021 | 2020 | |||
|---|---|---|---|---|
| Notes | g | 6 | ||
| Cash flows from operating activities Cash generated from operations |
I | (976,214) | 354,424 | |
| Net cash (used in)/provided | by operating | activities | (976,214) | 354,424 |
| Cash flows from investing Interest received |
activities | 128 | 239 | |
| Net cash provided by investing activities |
128 | 239 | ||
| Change in cash and cash the reporting period |
equivalents | in | (976,086) | 354,663 |
| Cash and cash equivalents beginning ofthe reporting |
at the period |
9811541 | 626,878 | |
| Cash and cash equivalents the reporting period |
at the end | of | 5,455 | 98L543 |
| RECONCILIATION | RECONCILIATION | OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING | OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING | OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING | OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING | OF NKT EXPENDITURE TO NET CASH FLOW FROM OPERATING | ||
|---|---|---|---|---|---|---|---|---|
| ACTIVITIES | ||||||||
| 2021 | 2020 | |||||||
| Net expenditure for the reporting Financial Activities) |
period (as per the Statement of | (167,320) | (67,345) | |||||
| Adjustments for: Interest received |
(128) | (239) | ||||||
| Increase in debtors | (28,837) | (//, 345) | ||||||
| (Decrease)/increase | in creditors | (779)929) | 433,353 | |||||
| Net cash (used in)/provided | by operations | (976,214) | 354,424 | |||||
| 2. | ANALYSIS OF CHANGES | IN NET FUNDS | ||||||
| At I/I/21 | Cash flow | At | 31/12/21 | |||||
| f, | 5 | |||||||
| Net cash | ||||||||
| Cash at bank | 981)541 | (9765086) | 5,455 | |||||
| 981,541 | (976,086) | 5,455 | ||||||
| Total | 981,541 | (976&086) | 5,455 |
| Further explanati | on | ofthe nature and purpose ofeach fund is | included in the notes to the financial |
statements. | |
|---|---|---|---|---|---|
| DONATIONS | AND | LEGACIES | |||
| 2021 | 2020 | ||||
| Donations | 149,015 | L242,676 | |||
| Legacies | 227,461 | 2,079 | |||
| 376,476 | L244,695 | ||||
| 3. | OTHER TRADING ACTIVITIES | ||||
| 2021 | 2020 | ||||
| g | |||||
| Fundraising events |
130,001 | 245,657 | |||
| 4. | INVESTMENT INCOME | ||||
| 2021 | 2020 | ||||
| 8 | 6 | ||||
| Deposit account interest | 128 | 239 | |||
| RAISING IiUNDS | |||||
| Raising donations | and legacies | 2021 | 2020 | ||
| 6 | |||||
| Staffcosts | 34,834 | 12L594 | |||
| Event expenses Support costs |
8)521 13,413 |
30,347 35,363 |
|||
| 56,768 | IB7,304 |
| 6. | CHARITABLE A | CTIVITIES COSTS | |||
|---|---|---|---|---|---|
| Grant | |||||
| funding of | |||||
| activities | |||||
| Direct | (see note | ||||
| Costs | 7) | Totals | |||
| 5 | 5 | 5 | |||
| Medical equipment | costs | 190 | 3)700 | 3,890 | |
| Other donations | 612,067 | 612,067 | |||
| 190 | 615,767 | 615,957 | |||
| 7. | GRANTS PAYABLE | ||||
| 2021 | 2020 | ||||
| 5 | |||||
| Medical equipment | costs | 3,700 | |||
| Other donations | 612,067 | ||||
| 615,767 | |||||
| 8. | SUPPORT COSTS | ||||
| Governance | |||||
| Finance | costs | Totals | |||
| 5 | 5 | 5 | |||
| Raising donations and legacies Other resources expended |
13,413 | 1,200 | 13)413 1,200 |
||
| 13,413 | 1,200 | 14)613 |
| 10. | STAIrF COSTS | 2021 | 2020 | ||||
|---|---|---|---|---|---|---|---|
| 8 | |||||||
| Wages and salaries | 34,834 | 127,594 | |||||
| 34,834 | 12L594 | ||||||
| The average monthly number ofemployees |
during the year was as follows: | ||||||
| 2021 | 2020 | ||||||
| Fundraising activities |
3 | 4 | |||||
| No employees received |
emoluments | in excess off60,000. | |||||
| 11. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES | ||||||
| Unrestricted | Restricted | Total | |||||
| fund 8 |
funds 6 |
fundsf | |||||
| INCOME AND ENDOWMENTS | FROM | ||||||
| Donations and legacies |
120,574 | 1,124,121 | 1,244,695 | ||||
| Other trading activities Investment income |
220,562 239 |
25,089 | 245,651 239 |
||||
| Total | 341,375 | 1,149,210 | 1,490,585 | ||||
| EXPENDITURE ON | |||||||
| Raising funds | 186,028 | 1,276 | 187,304 | ||||
| Charitable activities |
|||||||
| Medical equipment costs |
3,187 | 1,365,039 | 1,368,226 | ||||
| Other | 2,400 | 2,400 | |||||
| Total | 191,615 | 1,366,3 15 | 1,557,930 | ||||
| NET INCOME/(EXPENDITURE) | 149,760 | (217,105) | (67,345) | ||||
| Transfers between funds |
(122,013) | 122,013 | |||||
| Net movement in funds |
27,747 | (95,092) | (67,345) | ||||
| RECONCILIATION | OF FUNDS | ||||||
| Total funds brought | forward | 48,784 | 185,881 | 234,665 | |||
| TOTAL FUNDS CARRIED FORWARD | 76,531 | 90,789 | 167,320 |
| 2. | INTANGIBLE FIXED ASSETS | ||
|---|---|---|---|
| Database | |||
| cost | |||
| 5 | |||
| COST | |||
| At 1 January 2021 Disposals |
7,800 (7,800) |
||
| At 31 December 2021 | |||
| AMORTISATION | |||
| At 1 January 2021 Eliminated on disposal |
7,800 (7,800) |
||
| At 31December 2021 | |||
| NKT BOOI&VALUE | |||
| At 31December 2021 | |||
| At 31December 2020 | |||
| 13. | DEBTORS:AMOUNTS FALLING DUE WITHIN ONK YEAR | 2021 | 2020 |
| 8 | 8 | ||
| Trade debtors Gift aid due prepayments and accrued income |
54,246 | 8,970 /0, 050 6,389 |
|
| 54,246 | 25,409 | ||
| 14. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | 2021 | 2020 |
| 8 | 6 | ||
| Trade creditors Other creditors |
59,701 | 800,723 38,907 |
|
| 59,701 | 839,630 |
| MOVEMENT IN FUNDS | |||||
|---|---|---|---|---|---|
| Net | Transfers | ||||
| movement | between | At | |||
| At I/1/21 | in funds | funds | 31/12/21 | ||
| Unrestricted funds |
|||||
| General fund | 76,531 | (4,233) | (72,298) | ||
| Restricted funds |
|||||
| Closure | 60,000 | (61,000) | 1,000 | ||
| Radiology Elastography 2020 Iqoro Training Device |
14,742 580 |
(37,050) (9,562) |
22,308 8,982 |
||
| 2020 Dri Oct Opthlmology | 1,000 | (1,000) | |||
| HGF Fund | 7,668 | (7,668) | |||
| Baby Resus | 135 | (135) | |||
| Egg Deep Covid Emergency | Fund | 6,740 | (6,740) | ||
| Andover | 59 | (59) | |||
| 2020 Biometry for Opthoamology | (40&143) | 40,143 | |||
| 90,789 | (163,087) | 72,298 | |||
| TOTAL FUNDS | 1671320 | (167,320) | |||
| Net movement in funds, included |
in the above are as follows: | ||||
| Incoming | Resources | Movement | |||
| resources | expended | in funds | |||
| Unrestricted funds |
|||||
| General fund | 425,053 | (429,286) | (4,233) | ||
| Restricted funds | |||||
| Closure | (61)000) | (61,000) | |||
| Radiology Elastography 2020 Iqoro Training Device 2020 Dri Oct Opthlmology HGF Fund |
25,450 2,038 2,000 |
(629500) (11)600) (3,000) (7,668) |
(37,050) (9,562) (1,000) (7,668) |
||
| Baby Resus Dig Deep Covid Emergency Andover |
Fund | 135 | (6,740) (59) |
135 (60740) (59) |
|
| 2020 Biometry for Opthoamology 2020 Hologic Horizon Scanner |
250 50,000 |
(40,393) (50,000) |
(40,143) | ||
| 2021 Paceports | 1,679 | (1,679) | |||
| 81,552 | (244,639) | (163,087) | |||
| TOTAL FUNDS | 506,605 | (673,925) | (167,320) |
| Comparatives for movement |
in funds | ||||
|---|---|---|---|---|---|
| Net | Transfers | ||||
| movement | between | At | |||
| At 1/1/20 | in funds | funds | 31/12/20 | ||
| 6 | 6 | ||||
| Unrestricted funds General fund |
48,784 | 149,760 | (122,013) | 76,531 | |
| Restricted funds Closure Radiology Elastography Medical Photography Microbiology Maldi Urology Prostate Fusion Sys Colposcopy Advanced Resus |
45,000 17 42,646 61,423 27,207 |
11,554 (43,813) (50,000) 2,167 (38,070) |
15,000 3,188 (17) 1,167 (11,423) (2,167) 10,863 |
60,000 14,742 |
|
| Heart Andover 27k 2020 Haemorrhoids 2020 Vascular Ultrasound |
9,588 | (9,588) (8,990) (21,306) |
8,990 21,306 |
||
| 2020 Sleep Activity Monitor 2020 Tissue Viability SEM Scanner 2020 Feno Niox -Paediatrics |
(367) 15 95 |
367 (15) (95) |
|||
| 2020 Patient Transfer Scale 2020 Larynogograph 2020 Iqoro Training Device 2020 Neurotox |
(40) (1,670) 1,280 179 |
40 1,670 (700) (179) |
580 | ||
| 2020 Airvo 2 Optiflow 2020 Dri Oct Opthlmology Luninometer Pathology HGF Fund 2020 Slide Scanner Baby Resus Dig Deep Covid Emergency Andover |
Fund | 700 1,000 (4,378) 7,668 (66,725) (1,600) 4,725 59 |
(700) 4,378 66,725 1,600 2,015 |
1,000 7,668 6,740 59 |
|
| 185,881 | (217,105) | 122,013 | 90,789 | ||
| TOTAL FUNDS | 234,665 | (67,345) | 167,320 |
| Comparative net movemen |
t i |
n funds, included in the |
above are as follows: | ||
|---|---|---|---|---|---|
| Incoming | Resources | Movement | |||
| resources | expended | in funds | |||
| g | g | ||||
| Unrestricted funds |
|||||
| General fund | 341,375 | (191,615) | 149,760 | ||
| Restricted funds | |||||
| Radiology Ktastography Microbiology Maldi Urology Prostate Fusion Colposcopy Advanced Resus |
Sys | 7,916 3,025 2,167 20,646 |
3,638 (46,838) (50,000) (58,716) |
11,554 (43,813) (50,000) 2,167 (38,070) |
|
| Heart Andover 27k | 45 | (9,633) | (9,588) | ||
| 2020 Haemorrhoids | 2,010 | (11,000) | (8,990) | ||
| 2020 Vascular Ultrasound | (21,306) | (21,306) | |||
| 2020 Sleep Activity Monitor | 2,424 | (2,791) | (367) | ||
| 2020 Tissue Viability SEM Scanner | 15 | 15 | |||
| 2020 Droplet Hydration | System | 3,500 | (3,500) | ||
| 2020 Feno Niox - Paediatrics | 16,770 | (16,675) | 95 | ||
| 2020 Patient Transfer Scale | 2,430 | (2,470) | (40) | ||
| 2020 Larynogograph 2020 Iqoro Training Device 2020 Neurotox |
2,480 1,280 2,216 |
(4,150) (2,037) |
(1,670) 1,280 179 |
||
| 2020 Airvo 2 Optiflow | 700 | 700 | |||
| 2020Dri Oct Opthlmology Luninometer Pathology HGF Fund |
1,000 525 8,944 |
(4,903) (1,276) |
1,000 (4,378) 7,668 |
||
| 2020 Slide Scanner | 775 | (67,500) | (66,725) | ||
| Baby Resus Dig Deep Covid Emergency Andover |
Fund | 1,070,283 59 |
(1,600) (1,065,558) |
(1,600) 4,725 59 |
|
| 1,149,210 | (1,366,315) | (217,105) | |||
| TOTAL FUNDS | 1,490,585 | (1,557,930) | (67,345) |
| Net | Transfers | ||||
|---|---|---|---|---|---|
| movement | between | At | |||
| At I/1/20 | in funds | funds | 31/12/21 | ||
| Unrestricted funds |
|||||
| General fund | 48,784 | 145,527 | (194,311) | ||
| Restricted funds | |||||
| Closure | 45,000 | (61,000) | 16,000 | ||
| Radiology Blastography | (25,496) | 25,496 | |||
| Medical Photography | 17 | (17) | |||
| Microbiology Maldi |
42,646 | (43,813) | 1,167 | ||
| Urology Prostate Fusion Sys | 61,423 | (50,000) | (11,423) | ||
| Colposcopy | 2,167 | (2,167) | |||
| Advanced Resus |
27,207 | (38,070) | 10,863 | ||
| Heart Andover 27k | 9,588 | (9,588) | |||
| 2020 Haemorrhoids | (8,990) | 8,990 | |||
| 2020 Vascular Ultrasound | (21,306) | 21,306 | |||
| 2020 Sleep Activity Monitor | (367) | 367 | |||
| 2020 Tissue Viability SEM Scanner | 15 | (15) | |||
| 2020 Feno Niox - Paediatrics | 95 | (95) | |||
| 2020 Patient Transfer Scale | (40) | 40 | |||
| 2020 Larynogograph | (1,670) | 1,670 | |||
| 2020 Iqoro Training Device | (8,282) | 8,282 | |||
| 2020 Neurotox | 179 | (179) | |||
| 2020 Airvo 2 Optiflow | 700 | (700) | |||
| Luninometer Pathology |
(4,378) | 4,378 | |||
| 2020 Slide Scanner | (66,725) | 66,725 | |||
| Baby Resus Dig Deep Covid Emergency |
Fund | (1,465) (2,015) |
1,465 2,015 |
||
| 2020 Biometry for Opthoamology | (40,143) | 40,143 | |||
| 185,881 | (380,192) | 194,311 | |||
| TOTAL FUNDS | 234,665 | (234,665) |
| A current year 12 months and prior year 12 months as follows: |
combined net movement in f |
unds, included in |
the above are |
|---|---|---|---|
| Incoming | Resources | Movement | |
| resources | expended | in funds | |
| 6 | |||
| Unrestricted funds General fund |
766,428 | (620,901) | 145,527 |
| Restricted funds Closure Radiology Elastography Microbiology Maldi Urology Prostate Fusion Sys Colposcopy Advanced Resus Heart Andover 271& 2020 Haemorrhoids 2020 Vascular Ultrasound 2020 Sleep Activity Monitor 2020 Tissue Viability SEM Scanner 2020 Droplet Hydration System 2020 Feno Niox -Paediatrics 2020 Patient Transfer Scale 2020 Larynogograph 2020 Iqoro Training Device 2020 Neurotox 2020 Airvo 2 Optiflow 2020 Dri Oct Opthlmology Luninometer Pathology HGF Fund 2020 Slide Scanner Baby Resus Dig Deep Covid Emergency Fund Andover |
33,366 3,025 2,167 20,646 45 2,010 2,424 15 3,500 16,770 2,430 2,480 3,318 2,216 700 3,000 525 8,944 775 135 1,070,283 59 |
(61,000) (58,862) (46,838) (50,000) (58,716) (9633) (11,000) (21,306) (2,791) (3,500) (16,675) (2,470) (4,150) (11,600) (2,037) (3,000) (4,903) (8,944) (67,500) (1,600) (1,072,298) (59) |
(61,000) (25,496) (43,813) (50,000) 2,167 (38,070) (9,588) (8,990) (21,306) (367) 15 95 (40) (1,670) (8,282) 179 700 (4,378) (66,725) (1,465) (2,015) |
| 2020 Biometry for Opthoamology 2020 Hologic Horizon Scanner 2021 Paceports |
250 50,000 1,679 |
(40,393) (50,000) (1,679) |
(40,143) |
| 1,230,762 | (1,610,954) | (380,192) | |
| TOTAL FUNDS | 1,997,190 | (2,231,855) | (234,665) |
| 2021 | 2020 | |||
|---|---|---|---|---|
| 6 | ||||
| INCOME AND ENDOWMENTS | ||||
| Donations and legacies |
||||
| Donations | 149&015 | 1,242,616 | ||
| Legacies | 227,461 | 2,079 | ||
| 376&476 | 1,244,695 | |||
| Other trading activities |
||||
| Fundraising events |
130,001 | 245,651 | ||
| Investment income |
||||
| Deposit account interest | 128 | 239 | ||
| Total incoming resources |
506,605 | 1,490,585 | ||
| EXPENDITURE | ||||
| Raising donations | and legacies | |||
| Wages | 34)834 | 121,594 | ||
| Event expenses | 8,521 | 30,347 | ||
| 43,355 | 151,941 | |||
| Charitable activities |
||||
| Medical equipment | costs | 190 | 1,368,226 | |
| Grants to institutions | 615,767 | |||
| 615)957 | 1,368,226 | |||
| Support costs | ||||
| Finance | ||||
| Once costs | 9,637 | 21,984 | ||
| Bank charges | 1,298 | 10,383 | ||
| General expenses | 2,478 | 3,596 | ||
| 13,413 | 35,963 | |||
| Governance costs |
||||
| Independent examiner's |
fees | 1,200 | 1,800 | |
| Total resources expended | 673,925 | 1,557,930 | ||
| Net expenditure | (167,320) | (67,345) |